Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome : Hypoglycemia Treated by 90 Y Radioembolization - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Clinical Nuclear Medicine Année : 2017

Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome : Hypoglycemia Treated by 90 Y Radioembolization

Résumé

Solitary fibrous tumor is a rare type of mesenchymal neoplasm that can be associated to a paraneoplastic severe hypoglycemia due to the overproduction of insulinlike growth factor type 2: Doege-Potter syndrome. When surgical resection is impossible or unsuccessful, alternative therapies were described with heterogeneous efficiency. We report the use of radioembolization with 90 Y-labeled glass microspheres in this application. Regarding the excellent results obtained and the potential interest of peptide receptor radionuclide therapy suggested by overexpression of somatostatin receptors in our patient, the place of targeted radionuclide therapies deserves to be explored in this group of tumors.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-02484758 , version 1 (19-02-2020)

Identifiants

Citer

Clément Bailly, Myriam Bichali Alroumani, Frédéric Douane, Catherine Ansquer, Delphine Drui. Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome : Hypoglycemia Treated by 90 Y Radioembolization. Clinical Nuclear Medicine, 2017, 43 (3), pp.e93-e95. ⟨10.1097/RLU.0000000000001944⟩. ⟨inserm-02484758⟩
51 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More